Pandemic Dynamics, the three Waves of COVID-19 and the Way Ahead
Keywords:pandemic dynamics, SARS-CoV-2 waves, way ahead
Spread of a new pandemic in waves is a natural phenomenon. It has happened in past and also unfolding in present COVID-19 scenarios. Many players determine the outcome of the diseases during these waves of activities. This article discusses the past pandemics, lessons learnt from them and the 3 waves that have been recorded to date for SARS-CoV-2 (the novel coronavirus) and drawing parallel wherever feasible along with an element on its future course.
COVID-19 CORONAVIRUS PANDEMIC world meter; Last updated: Last updated: December 20, 2020, 10:09 GMT. www.worldometers.info (/coronavirus/)
WHO Health Emergency Dashboard WHO (COVID-19) Homepage
Novel Coronavirus (2019-nCoV) situation reports - World Health Organization (WHO).
The Deadliest Pandemics in History; Julia Tortorice; Nursing CE; OCTOBER 13, 2020. Copyright © CEUFast.com, 2015-2020. www.history.com/news/pandemics-end-plague-cholera-black-death-smallpox.
Nishiyama Y, Matsukuma S, Matsumura T, Kanatani Y, Saito T. Preparedness for a smallpox pandemic in Japan: public health perspectives. Disaster Med Public Health Prep. 2015 Apr;9(2):220-3. doi: 10.1017/dmp.2014.157. PMID: 26060873.
Sanfilippo-Borrás J. Algunas enfermedades y epidemias en torno a la Revolución Mexicana [Epidemics and disease during the Revolution Period in Mexico]. Rev Med Inst Mex Seguro Soc. 2010 Mar-Apr;48(2):163-6. Spanish. PMID: 20929620.
Strassburg MA. The global eradication of smallpox. Am J Infect Control. 1982 May;10(2):53-9. doi: 10.1016/0196-6553(82)90003-7. PMID: 7044193
ABBAS M. BEHBEHANI. The Smallpox Story: Life and Death of an Old Disease. MICROBIOLOGICAL REVIEWS, American Society for Microbiology Dec. 1983, Vol. 47. No. 4, p. 455-509
Haas C. La peste antonine [The Antonine plague]. Bull Acad Natl Med. 2006 Apr-May;190(4-5):1093-8. French. PMID: 17195627.
Sáez A. La peste Antonina: una peste global en el siglo II d.C [The Antonine plague: A global pestilence in the II century d.C]. Rev Chilena Infectol. 2016 Apr;33(2):218-21
COLLINGWOOD F. THE GREAT PLAGUE OF LONDON, 1665. Nurs Times. 1965 Apr 30;61:591.
Sloan AW. Medical and social aspects of the great plague of London in 1665. S Afr Med J. 1973 Feb 17;47(7):270-6.
EDWARDIAN PROMENADE. Living With ‘Enza: The Spanish Flu Pandemic, 1918-1919.HEALTH. YOUR #1 SOURCE FOR EDWARDIAN HISTORY! FEBRUARY 12, 2012
Nickol ME, Kindrachuk J. A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918-1919. BMC Infect Dis. 2019 Feb 6;19(1):117. doi: 10.1186/s12879-019-3750-8.
Aubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006 Jan;12(1):15-22.
Martini M, Gazzaniga V, Bragazzi NL, Barberis I. The Spanish Influenza Pandemic: a lesson from history 100 years after 1918. J Prev Med Hyg. 2019 Mar 29;60(1):E64-E67.
He, D., Dushoff, J., Day, T. et al. Mechanistic modelling of the three waves of the 1918 influenza pandemic. Theor Ecol 4, 283–288 (2011).
Gary Finnegan. 100 YEARS AFTER ‘SPANISH FLU’: IS THE WORLD READY FOR THE NEXT PANDEMIC? October 24th, 2018, Vaccines Europe.
Taubenberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12(1):15–22
Martini M, Gazzaniga V, Bragazzi NL, Barberis I. The Spanish Influenza Pandemic: a lesson from history 100 years after 1918. J Prev Med Hyg. 2019 Mar 29;60(1): E64-E67
Morens DM, Taubenberger JK, Harvey HA, Memoli MJ. The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med. 2010;38(4 Suppl): e10–20
Taubenberger JK. The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc. 2006 Mar;150(1):86-112
Nickol, M.E., Kindrachuk, J. A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918–1919. BMC Infect Dis 19, 117 (2019)
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020. Jan 30
Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020 Jun;26(6):729-734.
Kaur N, Singh R, Dar Z, Bijarnia RK, Dhingra N, Kaur T. Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2. Infect Genet Evol. 2020 Jul 31:104490
Daniele Mercatelli, Federico M. Giorgi. Geographic and Genomic Distribution of SARS-CoV-2Mutations. Frontiers in Microbiology, 2020; 11 DOI: 10.3389/fmicb.2020.01800
Università di Bologna. "The six strains of SARS-CoV-2." ScienceDaily. ScienceDaily,3 August 2020.
Weekly epidemiological update-8 December 2020. Data, as received by WHO from national authorities, as of 10, am CET 6 December 2020.8 December 2020; | Emergency Situational Updates
Mercatelli D and Giorgi FM (2020) Geographic and Genomic Distribution of SARS-CoV-2 Mutations. Front. Microbiol. 11:1800.
Justin Moore, MD, The Kansas Business Group on Health (KBGH). Social isolation doesn’t cause recessions – pandemics do. Posted on 17 Apr 2020
Goyal R. Measurement of Contagiousness/ Infectiousness/ Transmissibility of Infectious Agent. J Adv Res Med Sci Tech 2020; 7(1): 1-3.
Minah Park, Alex R. Cook *, Jue Tao Lim, Yinxiaohe Sun and Borame L. Dickens. A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. J. Clin. Med. 2020, 9, 967,1-13
James Gallagher. Covid vaccine: First 'milestone' vaccine offers 90% protection. BBC News. 8th December 2020.
Mishra B, Sinha ND, Mishra MB, Mishra MG. Is ‘FAR UVC’ the Nearest Solution for Pandemic Containment? J Adv Res Med Sci Tech 2020; 7(3): 27-31.
Mishra B, Mohapatra SC. Nasal ACE 2 receptors’ the gateway to COVID 19? J Community Health Manag 2020;7(3):68-69.
Copyright (c) 2021 Journal of Advanced Research in Medical Science & Technology (ISSN: 2394-6539)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.